Evaluation of apelin level with oxidative stress in thyroid patients
DOI:
https://doi.org/10.54153/sjpas.2021.v3i2.195Keywords:
Apelin , Thyroid Hormone (T3, T4, TSH) , GSH, MDAAbstract
The study aimed peptide apelin with thyroid diseases in both sexes injured thyroid disease in Samarra city, 90 serum samples, 60 for unisex with thyroid diseases (30 for hyperthyroidism, 30 for hypothyroidism and 30 for euthyroidism gland) with age ranging (45-60) years, and samples for healthy unisex as a control a group in Samarra general hospital. A significant Height in serum the patients T3 and T4 its decline in hyperthyroidism group compare with hypo, healthy group, were the level of TSH significantly increased in sera for total hypothyroidism gland, as decline compare with the hyperthyroidism and control group. A significant height in level concentration ( MDA) levels for patients hypothyroidism and little height in patents hyperthyroidism, but level GSH significant in decrease more in patients hypothyroidism and a significant lower in patients hyperthyroidism a group.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Samarra Journal of Pure and Applied Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Notice
Authors retain copyright and grant the SJPAS journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in Samarra Journal of Pure and Applied Science.
The Samarra Journal of Pure and Applied Science permits and encourages authors to archive Pre-print and Post-print items submitted to the journal on personal websites or institutional repositories per the author's choice while providing bibliographic details that credit their submission, and publication in this journal. This includes the archiving of a submitted version, an accepted version, or a published version without any Risks.
